United States: Yearly Stock Market Performance Insight - 2005

Yearly Gainers
1,013
Yearly Losers
910
Average Return
65.05%
Total Stocks
2,025
View Detailed Market Cap Breakdown
Market CapYearly GainersYearly LosersAverage ReturnTotal Stocks
Mega Cap 21 15 15.74% 36
Large Cap 324 148 16.05% 484
Mid Cap 252 195 9.17% 466
Small Cap 71 97 6.25% 180

Yearly Streak Leaders for 2005

Stock Streak Streak Return
7 years โ†‘ 1,036.01%

UnitedHealth solidifies its market leadership with a 7-year growth streak (5.47 โ†’ 62.14), delivering 1,036.0% cumulative returns. With 109.6B annual revenue generating only 6.5B profit (5.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

5 years โ†‘ 48.18%

Procter & Gamble solidifies its market leadership with a 5-year growth streak (39.06 โ†’ 57.88), delivering 48.2% cumulative returns. Annual financials validate this performance: 19.8B revenue generating 3.8B net profit (19.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

7 years โ†“ -53.68%

AT&T struggles through multi-year headwinds with a 7-year decline (39.94 โ†’ 18.50), down 53.7% cumulatively. Yet fundamentals remain solid: 30.6B annual revenue generating 4.7B profit (15.3% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

2 years โ†“ -29.72%

Cisco Systems navigates difficult years with a 2-year decline (24.36 โ†’ 17.12), down 29.7% cumulatively. Yet fundamentals remain solid: 14.1B annual revenue generating 2.5B profit (17.6% margin) as of Qtr ending Apr 2025 suggests this could be a value opportunity. Contrarian investors take note.

15 years โ†‘ 5,353.57%

Brown & Brown demonstrates exceptional long-term growth with a 15-year growth streak (0.28 โ†’ 15.27), delivering 5,353.6% cumulative returns. Annual financials validate this performance: 1.4B revenue generating 334.0M net profit (24.1% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

12 years โ†‘ 3,491.49%

Expeditors continues its impressive multi-year expansion with a 12-year growth streak (0.94 โ†’ 33.76), delivering 3,491.5% cumulative returns. With 2.7B annual revenue generating only 204.1M profit (7.7% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

5 years โ†“ -64.07%

Merck & Co faces prolonged challenges with a 5-year decline (84.42 โ†’ 30.33), down 64.1% cumulatively. Yet fundamentals remain solid: 15.5B annual revenue generating 5.1B profit (32.7% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

4 years โ†“ -80.49%

Tenet Healthcare faces prolonged challenges with a 4-year decline (157.07 โ†’ 30.64), down 80.5% cumulatively. Weak margins on 5.2B annual revenue with only 622.0M profit (11.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

11 years โ†‘ 1,266.54%

Simpson demonstrates exceptional long-term growth with a 11-year growth streak (2.66 โ†’ 36.35), delivering 1,266.5% cumulative returns. Annual financials validate this performance: 538.9M revenue generating 77.9M net profit (14.5% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

9 years โ†‘ 2,538.46%

Oshkosh demonstrates exceptional long-term growth with a 9-year growth streak (1.69 โ†’ 44.59), delivering 2,538.5% cumulative returns. With 2.3B annual revenue generating only 112.2M profit (4.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

4 years โ†“ -76.59%

Ionis faces prolonged challenges with a 4-year decline (22.38 โ†’ 5.24), down 76.6% cumulatively. Financial struggles compound yearly losses: despite 131.6M annual revenue, - 146.9M losses persist (-111.6% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

2 years โ†“ -94.06%

Ies Holdings sees continued yearly losses with a 2-year decline (158.27 โ†’ 9.40), down 94.1% cumulatively. Annual revenue of 834.0M provides stability, but 72.6M net income (8.7% margin) in Qtr ending Mar 2025 highlights operational challenges requiring strategic shifts.

6 years โ†‘ 1,165.14%

Pediatrix Medical solidifies its market leadership with a 6-year growth streak (1.75 โ†’ 22.14), delivering 1,165.1% cumulative returns. While annual revenue reaches 458.4M, net income of 20.7M (4.5% margin) in Qtr ending Mar 2025 shows the company prioritizes growth over margins - common for expanding Healthcare players.

6 years โ†‘ 612.00%

National Healthcare continues its impressive multi-year expansion with a 6-year growth streak (5.25 โ†’ 37.38), delivering 612.0% cumulative returns. With 373.7M annual revenue generating only 32.3M profit (8.6% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

3 years โ†“ -43.92%

La-Z-Boy sees continued yearly losses with a 3-year decline (24.18 โ†’ 13.56), down 43.9% cumulatively. Weak margins on 570.9M annual revenue with only 15.4M profit (2.7% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.

2 years โ†“ -49.44%

IDT navigates difficult years with a 2-year decline (58.68 โ†’ 29.67), down 49.4% cumulatively. Weak margins on 302.0M annual revenue with only 23.0M profit (7.6% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.

United States Market Yearly Gainers & Losers: 2005

Top United States Stock Gainers (2005)

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYear Volume
$1.16 $2.57 123.48% 723.81M 182.40B
$1.80 $3.87 119.89% 10.64M 2.68B
$4.94 $10.38 115.35% 427.14M 107.64B
$4.10 $8.01 88.92% 4.87M 1.23B
$0.20 $0.30 50.00% 617.13M 155.52B
$0.39 $1.64 331.58% 44.62M 11.24B
$3.50 $11.73 245.00% 2.55M 642.88M
$4.45 $13.03 192.81% 6.94M 1.75B
$7.03 $18.96 175.98% 1.26M 317.69M
$10.70 $27.67 161.78% 1.30M 326.34M
$6.35 $21.02 233.65% 753.60K 189.91M
$5.20 $16.83 224.28% 82.99K 20.91M
$5.99 $16.75 189.79% 1.24M 311.51M
$1.73 $5.03 179.44% 5.44K 1.37M
$4.25 $10.71 152.00% 549.83K 138.56M
$2.40 $8.60 258.33% 287.59K 72.47M
$2.33 $6.25 171.74% 192.21K 48.44M
$3.53 $9.40 158.95% 81.44K 20.52M
$3.38 $7.80 135.65% 707.28K 178.24M
$5.00 $10.76 111.81% 421.38K 106.19M

Biggest United States Stock Losers (2005)

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYear Volume
$94.62 $78.59 -16.61% 6.39M 1.61B
$22.31 $18.92 -15.46% 8.83M 2.23B
$27.43 $23.65 -13.75% 7.35M 1.85B
$17.92 $15.60 -11.41% 39.46M 9.94B
$19.42 $17.12 -11.39% 55.52M 13.99B
$32.35 $6.96 -78.01% 5.28M 1.33B
$2.08 $0.94 -54.81% 51.58K 13.00M
$14.66 $7.72 -47.27% 13.52M 3.41B
$10.00 $5.34 -46.55% 1.00M 253.19M
$9.50 $5.09 -46.02% 3.26M 820.38M
$81.19 $9.40 -88.64% 39.57K 9.97M
$22.00 $5.49 -74.58% 148.56K 37.44M
$7.26 $2.28 -68.33% 105.83K 26.67M
$5.66 $2.00 -64.66% 1.07K 269.70K
$472.50 $186.15 -60.92% 42.83K 10.79M
$10.01 $3.46 -64.84% 115.57K 29.12M
$28.40 $12.36 -56.34% 189.39K 47.73M
$90.00 $40.00 -55.56% - -
$7.16 $3.34 -52.76% 149.26K 37.61M
$79.10 $42.10 -47.38% 4.56K 1.15M

Most Active United States Stocks During 2005

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYearly Volume
$1.16 $2.57 123.48% 723.81M 182.40B
$0.20 $0.30 50.00% 617.13M 155.52B
$4.94 $10.38 115.35% 427.14M 107.64B
$2.25 $2.36 6.79% 143.29M 36.11B
$26.80 $26.15 -2.13% 66.61M 16.79B
$23.64 $24.96 6.71% 58.53M 14.75B
$24.66 $18.19 -25.69% 51.45M 12.97B
$0.39 $1.64 331.58% 44.62M 11.24B
$25.91 $22.13 -13.25% 30.77M 7.75B
$11.09 $8.64 -22.09% 27.63M 6.96B
$4.79 $4.41 -7.93% 27.65M 6.97B
$27.75 $22.00 -19.91% 24.39M 6.15B
$7.65 $7.05 -7.84% 17.30M 4.36B
$14.56 $10.74 -25.57% 9.58M 2.41B
$28.93 $33.17 14.78% 5.11M 1.29B
$14.11 $23.59 68.74% 5.28M 1.33B
$16.11 $15.32 -2.42% 4.77M 1.20B
$5.15 $5.05 -1.75% 4.65M 1.17B
$15.56 $15.38 -0.65% 3.10M 781.04M
$9.86 $6.84 -30.49% 3.07M 774.36M

United States Sector Performance During 2005

Technology

385.13%
266 stocks
Top Performers by Market Cap:
Mega Cap: AAPL +123.48%
Large Cap: WDC +71.79%
Small Cap: UCTT +19.47%

Energy

49.11%
90 stocks
Top Performers by Market Cap:
Mega Cap: XOM +9.58%
Large Cap: CNQ +131.87%
Small Cap: RES +135.65%

Basic Materials

27.83%
113 stocks
Top Performers by Market Cap:
Mega Cap: LIN +19.95%
Large Cap: RGLD +90.41%
Small Cap: SA +158.95%

Healthcare

25.45%
247 stocks
Top Performers by Market Cap:

Industrials

18.51%
314 stocks
Top Performers by Market Cap:
Mega Cap: GE -3.97%
Large Cap: WCN +118.13%
Small Cap: DXPE +258.33%

Utilities

8.79%
60 stocks
Top Performers by Market Cap:
Large Cap: WTRG +48.07%
Mid Cap: ORA +60.57%
Small Cap: SJW +25.00%

Consumer Cyclical

8.27%
240 stocks
Top Performers by Market Cap:
Mega Cap: AMZN +6.79%
Large Cap: TSCO +42.47%
Small Cap: CRI +73.06%

Financial Services

7.80%
397 stocks
Top Performers by Market Cap:
Mega Cap: AXP +4.30%
Large Cap: NDAQ +245.00%
Mid Cap: NNI +51.06%
Small Cap: PFBC +102.28%

Consumer Defensive

5.52%
100 stocks
Top Performers by Market Cap:
Mega Cap: PG +5.08%
Large Cap: MNST +331.58%
Mid Cap: FLO +30.93%
Small Cap: ANDE +68.94%

Real Estate

5.34%
109 stocks
Top Performers by Market Cap:
Large Cap: SBAC +92.89%
Small Cap: SHO +27.86%

Communication Services

-3.17%
68 stocks
Top Performers by Market Cap:
Mega Cap: NFLX +119.89%
Large Cap: RCI +61.67%
Small Cap: ZD +23.87%

Data is updated regularly. Yearly performance is calculated based on closing prices.